CURRENT
ISSUE
1717

Influenza is generally a self-limited illness, but pneumonia, respiratory failure, and death can occur, especially in persons at increased risk for influenza complications (see Table 1). Updated information on influenza activity and antiviral resistance is available from the CDC at cdc.gov/flu.

TREATMENT OF INFLUENZA — Three neuraminidase inhibitors (oral oseltamivir, IV peramivir, and inhaled zanamivir) and the oral cap-dependent endonuclease inhibitor baloxavir marboxil are available in the US...  Continue reading

Coming Soon
Drugs for Age-Related Macular Degeneration
Vyalev — A Foscarbidopa/Foslevodopa Subcutaneous Infusion for Parkinson’s Disease
Guselkumab (Tremfya) for Ulcerative Colitis